Ezequiel Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ezequiel Rodríguez has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Elsa Solà
Liver Unit, IDIBAPS, CIBEReHD, Faculty of Medicine and Health Sciences, Hospital Clinic of Barcelona University of Barcelona Barcelona Spain
9 shared publications - Pere Ginès
Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain
9 shared publications Mónica Guevara
Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain; Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED), Spain; Instituto Reina Sofía de Investigación Nefrológica (IRSIN), Spain
7 shared publications- Vicente Arroyo
European Foundation for the Study of Chronic Liver Failure, Barcelona, Spain
7 shared publications Javier Fernández
Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain; Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED), Spain; Instituto Reina Sofía de Investigación Nefrológica (IRSIN), Spain
6 shared publicationsRogelio Barreto
Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain; Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED), Spain; Instituto Reina Sofía de Investigación Nefrológica (IRSIN), Spain
6 shared publications
Latest Publications
- Open Access
- 1 February 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (2) , 493-495
Transient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndrome
- 1 February 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62 (2) , 493-495
Open AccessTransient increase in urine protein excretion during treatment with terlipressin and albumin for type-1 hepatorenal syndrome
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis
Objective Prognostic stratification of patients with cirrhosis is common clinical practice. This study compares the prognostic accuracy (28-day and 90-day transplant-free mortality) of the acute-on-chronic liver failure (ACLF) classification (no ACLF, ACLF grades 1, 2 and 3) with that of acute kidney injury (AKI) classification (no AKI, AKI stages 1, 2 and 3). Design The study was performed in 510 patients with an acute decompensation of cirrhosis previously included in the European Association for the Study of the Liver–Chronic Liver Failure consortium CANONIC study. ACLF was evaluated at enrolment and 48 h after enrolment, and AKI was evaluated at 48 h according to Acute Kidney Injury Network criteria. Results 240 patients (47.1%) met the criteria of ACLF at enrolment, while 98 patients (19.2%) developed AKI. The presence of ACLF and AKI was strongly associated with mortality. 28-day transplant-free mortality and 90-day transplant-free mortality of patients with ACLF (32% and 49.8%, respectively) were significantly higher with respect to those of patients without ACLF (6.2% and 16.4%, respectively; both pConclusions ACLF stratification is more accurate than AKI stratification in the prediction of short-term mortality in patients with acute decompensation of cirrhosis.
Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis
Objective Prognostic stratification of patients with cirrhosis is common clinical practice. This study compares the prognostic accuracy (28-day and 90-day transplant-free mortality) of the acute-on-chronic liver failure (ACLF) classification (no ACLF, ACLF grades 1, 2 and 3) with that of acute kidney injury (AKI) classification (no AKI, AKI stages 1, 2 and 3). Design The study was performed in 510 patients with an acute decompensation of cirrhosis previously included in the European Association for the Study of the Liver–Chronic Liver Failure consortium CANONIC study. ACLF was evaluated at enrolment and 48 h after enrolment, and AKI was evaluated at 48 h according to Acute Kidney Injury Network criteria. Results 240 patients (47.1%) met the criteria of ACLF at enrolment, while 98 patients (19.2%) developed AKI. The presence of ACLF and AKI was strongly associated with mortality. 28-day transplant-free mortality and 90-day transplant-free mortality of patients with ACLF (32% and 49.8%, respectively) were significantly higher with respect to those of patients without ACLF (6.2% and 16.4%, respectively; both pConclusions ACLF stratification is more accurate than AKI stratification in the prediction of short-term mortality in patients with acute decompensation of cirrhosis.
- 1 July 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 61 (1) , 35-42
Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections
- 1 July 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 61 (1) , 35-42
Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections
- 1 May 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (5) , 955-961
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
- 1 May 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (5) , 955-961
Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis
- 1 September 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 59 (3) , 474-481
A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis
- 1 September 2013
- Published by Elsevier in Journal of Hepatology
- Vol. 59 (3) , 474-481
A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis
- Open Access
- 19 August 2013
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (4) , 1505-1513
Type-1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival
Type-1 hepatorenal syndrome (HRS) is a common complication of bacterial infections in cirrhosis, but its natural history remains undefined. To assess the outcome of kidney function and survival of patients with type-1 HRS associated with infections, 70 patients diagnosed during a 6-year period were evaluated prospectively. Main outcomes were no reversibility of type-1 HRS during treatment of the infection and 3-month survival. Forty-seven (67%) of the 70 patients had no reversibility of type-1 HRS during treatment of the infection. [Correction to previous sentence added March 10, 2014, after first online publication: “Twenty-three (33%)” was changed to “Forty-;seven (67%).”] The main predictive factor of no reversibility of type-1 HRS was absence of infection resolution (no reversibility: 96% versus 48% in patients without and with resolution of the infection; P < 0.001). Independent predictive factors of no reversibility of type-1 HRS were age, high baseline serum bilirubin, nosocomial infection, and reduction in serum creatinine Conclusion: Type-1 HRS associated with infections is not reversible in two-thirds of patients with treatment of infection only. No reversibility of type-1 HRS is associated with lack of resolution of the infection, age, high bilirubin, and no early improvement of kidney function and implies a poor prognosis. These results may help advance the management of patients with type-1 HRS associated with infections. (HEPATOLOGY 2014;59:1505-1513)
- 19 August 2013
- Published by Wolters Kluwer Health in Hepatology
- Vol. 59 (4) , 1505-1513
Open AccessType-1 hepatorenal syndrome associated with infections in cirrhosis: Natural history, outcome of kidney function, and survival
Type-1 hepatorenal syndrome (HRS) is a common complication of bacterial infections in cirrhosis, but its natural history remains undefined. To assess the outcome of kidney function and survival of patients with type-1 HRS associated with infections, 70 patients diagnosed during a 6-year period were evaluated prospectively. Main outcomes were no reversibility of type-1 HRS during treatment of the infection and 3-month survival. Forty-seven (67%) of the 70 patients had no reversibility of type-1 HRS during treatment of the infection. [Correction to previous sentence added March 10, 2014, after first online publication: “Twenty-three (33%)” was changed to “Forty-;seven (67%).”] The main predictive factor of no reversibility of type-1 HRS was absence of infection resolution (no reversibility: 96% versus 48% in patients without and with resolution of the infection; P < 0.001). Independent predictive factors of no reversibility of type-1 HRS were age, high baseline serum bilirubin, nosocomial infection, and reduction in serum creatinine Conclusion: Type-1 HRS associated with infections is not reversible in two-thirds of patients with treatment of infection only. No reversibility of type-1 HRS is associated with lack of resolution of the infection, age, high bilirubin, and no early improvement of kidney function and implies a poor prognosis. These results may help advance the management of patients with type-1 HRS associated with infections. (HEPATOLOGY 2014;59:1505-1513)
- 1 December 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (6) , 1199-1206
Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema
- 1 December 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (6) , 1199-1206
Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema
- 1 August 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (2) , 267-273
Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis
- 1 August 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 57 (2) , 267-273
Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis
- 1 May 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (5) , 1040-1046
Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study
- 1 May 2012
- Published by Elsevier in Journal of Hepatology
- Vol. 56 (5) , 1040-1046
Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study